Prospective Liver Tumor (ProLiT) Database
NCT01607788 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2012-05-30
Summary
The investigators propose a prospective, web-based database (developed within the framework of Quickbase, Intuit) which will allow an evaluation of the data for patients with a liver tumour who receive a liver transplant. Each site will continue to transplant according to their own criteria for inclusion on the waiting list. Each center will be responsible to enter a short list of data points at time of listing, transplant, and at 1 and 2 years post transplant. Data will be gathered prospectively through a web-based anaonymized database, and outcomes analyzed yearly X5 for tumour recurrence and patient survival.
Conditions
- Hepatocellular Carcinoma
- Evidence of Liver Transplantation
Sponsors & Collaborators
-
University of Alberta
collaborator OTHER -
London Health Sciences Centre
collaborator OTHER -
University of Bern
collaborator OTHER -
University Hospital, Geneva
collaborator OTHER -
University of Geneva, Switzerland
lead OTHER
Principal Investigators
-
Norman Kneteman, MD, PhD · University of Geneva
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Completion
- 2017-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Biochemical and Genetic Markers in Liver Diseases
NCT01706614 ·Status: UNKNOWN
-
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
NCT04499833 ·Status: RECRUITING ·Phase: NA
-
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
NCT05866783 ·Status: RECRUITING
-
Utilization of MAsS in Patients Undergoing LT for HCC
NCT05184283 ·Status: TERMINATED
-
A National Registry of Patients With Hepatocellular Carcinoma
NCT00178867 ·Status: COMPLETED
-
Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates
NCT05276037 ·Status: RECRUITING
-
Non Transplantable Recurrence After Percutaneous Thermal Ablation of HCC
NCT05202184 ·Status: COMPLETED
-
Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
NCT06523608 ·Status: RECRUITING
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
LSM and SSM for the Diagnosis of CSPH: a Prospective Cohort Study
NCT06181409 ·Status: RECRUITING
-
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
NCT05106322 ·Status: RECRUITING
-
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
NCT05312853 ·Status: NOT_YET_RECRUITING
-
HCC Innervation Assessment
NCT06886763 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization and Pathogenesis of ACLF
NCT04975490 ·Status: RECRUITING
-
PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)
NCT01320852 ·Status: COMPLETED ·Phase: NA
-
Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma
NCT02145013 ·Status: UNKNOWN
-
Prospective Cohort of Patients With Hepatocellular Carcinoma in France
NCT04348838 ·Status: RECRUITING
-
Liver and Biliary Tumor Tissue Registry
NCT02917759 ·Status: TERMINATED
-
Liver Regeneration
NCT03396705 ·Status: TERMINATED
-
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
NCT07051863 ·Status: RECRUITING
-
Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts
NCT07101718 ·Status: COMPLETED
-
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
NCT07036874 ·Status: RECRUITING
-
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
NCT04191044 ·Status: UNKNOWN
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA